Back to Articles
// HIV PREVENTION

Cabotegravir (CAB-LA): Long-Acting Protection

Purity M. Nyatondo 4 min read HIV Prevention
Cabotegravir CAB-LA Injectable PrEP

Long-acting injectable Cabotegravir (CAB-LA) is an effective HIV prevention option given as an intramuscular injection in the gluteal (buttock) muscle. After two initial loading injections given one month apart, CAB-LA is administered once every two months.

How CAB-LA Protects You

Cabotegravir is an integrase strand transfer inhibitor (INSTI). It prevents HIV from inserting its viral DNA into the DNA of human immune cells (CD4 cells), stopping the virus from multiplying in your body.

Key Benefits of CAB-LA

  • Bi-monthly schedule: Six injections per year after the initial start-up doses keep protection steady.
  • No daily pill burden: Ideal for people who struggle with daily routines or travel frequently.
  • Broadly accessible in Southern Africa: Rolled out across public clinics and youth-friendly health centers in countries like Zimbabwe.

Staying on Track

Always attend your scheduled follow-up appointments for HIV testing and your next dose. If you decide to stop CAB-LA, talk to a healthcare worker about transitioning smoothly to another HIV prevention method such as Oral PrEP or condoms.